FDA’s Peter Stein On Hitting The ‘Persuasive Evidence’ Bar For Rare Disease Drug Repurposing

 
• By Sarah Karlin-Smith
  
old bicycle used as planter
The regulatory pathway can be simpler for repurposed drugs, the FDA’s Peter Stein said. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet